Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
3.43
Sep. 22, 2023 15:10:54- Change -0.11 (-3.1073%)
- Volume 3,713
- Today's Open 3.45
- Previous Close 3.54
- Today's High 3.6
- Today's Low 3.4121
- 52 Week High 8.73
- 52 Week Low 1.998